Epi One's groundbreaking cancer diagnosis technology seeks to change the lives of millions or people every single year by detecting cancer accurately enough to treat appropriately and early enough to cure.

Many cancers are treatable when diagnosed early. But traditional screening methods, like X-rays, CAT scans and even genomic sequencing tests, can take several days, weeks, or even months for results. They can be expensive and they can be inaccurate. Far too many people don’t receive a cancer diagnosis until it’s too late.

As a result, cancer is the second leading cause of death globally.

At Epi One, we believe we can change this. We believe we can save millions of lives every year by diagnosing cancer early, accurately and affordably. Our transformational cancer screening process is as simple as a blood test, and is faster, cheaper and more accurate than anything else available.

Our scientific team is pioneering disruptive DNA-based biomarker identification technologies.